Avulux
PrivateLast Round
Accelerator
Mar 24, 2025
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Avulux is a therapeutic device company that develops and markets precision-engineered migraine and light sensitivity lenses.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, D2C Brands, Clinical Trials
Business Model
B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avulux Comparables
Compare Avulux with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TheraSpecs | 84% | |
| Sleepaxa Private Limited | 83% | |
| MigraLens | 81% |
Avulux Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Mar 24, 2025 |
Avulux Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Consortium for Technology & Innovation in Pediatrics | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors increased 31% MoM.
- Apr 6, 2025
Grew 16% QoQ, from 19 to 22 employees.
Avulux Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Avulux's valuation, stock price, and market status.
Is Avulux a public or private company?
Avulux is a private company.
What is the current stock price of Avulux?
Avulux is a private company, so its shares have no public market price. Caplight tracks Avulux's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Avulux worth (valuation)?
Valuation information for Avulux is not publicly available.
Can I buy Avulux stock?
Avulux shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Avulux's last funding round?
Avulux's most recent funding round was Accelerator on March 24, 2025.
Who are the main investors in Avulux?
Key investors in Avulux include The Consortium for Technology & Innovation in Pediatrics.
Will Avulux IPO soon?
No public IPO plans have been announced for Avulux.
How can I track Avulux secondary market activity?
Caplight tracks bids, offers, and trades in Avulux's shares on secondary markets.